You can find the annual or quarterly income statement of Arrivent Biopharma Inc here for insights into the performance and operational efficiency of Arrivent Biopharma Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2022Q4

FY2022Q3

Operating expenses

58.12%38.32M

30.84%33.62M

222.98%66.77M

2.54%23.70M

44.96%24.23M

--25.70M

--20.67M

121.39%23.12M

42.05%16.72M

--10.44M

--11.77M

R&D expenses

60.13%32.17M

27.28%27.72M

261.05%61.29M

0.76%20.16M

40.67%20.09M

--21.78M

--16.98M

131.41%20.01M

41.54%14.28M

--8.65M

--10.09M

Operating profit

-58.12%-38.32M

-30.84%-33.62M

-222.98%-66.77M

-2.54%-23.70M

-44.96%-24.23M

---25.70M

---20.67M

-121.39%-23.12M

-42.05%-16.72M

---10.44M

---11.77M

Net non-operating interest income (expenses)

Non-operating interest income

-9.00%3.34M

-41.83%2.22M

-26.77%2.38M

59.58%3.07M

58.44%3.67M

--3.82M

--3.26M

--1.93M

--2.31M

----

--0.00

Special income (expenses)

----

--0.00

----

Income before tax

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Income after tax

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Net income from continuous operations

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Net income attributable to controlling interests

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Net income attributable to common shareholders

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Basic earnings per share

-36.28%-0.83

-37.38%-0.90

-173.14%-1.90

7.72%-0.61

-35.89%-0.61

---0.65

---0.70

-102.96%-0.66

-22.37%-0.45

---0.33

---0.37

Diluted earnings per share

-36.28%-0.83

-37.38%-0.90

-173.14%-1.90

7.72%-0.61

-35.89%-0.61

---0.65

---0.70

-102.96%-0.66

-22.37%-0.45

---0.33

---0.37

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

